What's next in treatments for cancer patients with solid tumors?

Vancouver, kelowna, and delta, british columbia--(newsfile corp. - june 20, 2024) - investorideas.com, a go-to investing platform, releases an industry snapshot looking at the future treatment of solid cancer tumors, featuring aethlon medical, inc. (nasdaq: aemd), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases. read the full article on investorideas.com https://www.investorideas.com/news/2024/biotech/06200treatments-for-cancer-patients-with-solid-tumors.asp research released this year predicts, "the solid tumor therapeutics market size will grow from usd 222.71 billion in 2023 to usd 885.44 billion in 10 years.
AEMD Ratings Summary
AEMD Quant Ranking